Sessions
A CGT Retrospective: Best Practice & Evidence Generation for Pricing, Reimbursement & Regulatory Approval
CAR-T & Beyond: Future Cell Based Immunotherapeutic Strategies
Starting with the End in Mind: Translating Academic Research into Commercial Products
Innovative Technologies as a Driver of European CGT Commercialisation & Successful Market Adoption
Cross Country Collaboration for Development, Commercialisation and Access
The EU Health Technology Assessment Regulations: Pricing & Reimbursement Opportunities of Novel Therapeutics in Europe
Disruptive Developments Digitalisation, AI and Virtualisation Supporting ATMP Progress
A CGT Retrospective: Best Practice & Evidence Generation for Pricing, Reimbursement & Regulatory Approval
06 Sep 2023
16:00
Stream 2
16:00pm Chair Introduction
Chairperson: Miguel Forte, CEO, Kiji Therapeutics President-Elect, ISCT
Panel Participants
- Mantej Chhina, Executive Director, Head of Global R&D Regulatory Policy, BioMarin
- Julia Djonova, Head of the Advanced Therapy Medicinal Products, Swissmedic
- Robert Allen, Managing Partner, General Manager, Dark Horse Consulting
- Paolo Morgese, Head of Public Affairs, Europe, Alliance for Regenerative Medicine
Speakers
